复方甘草酸苷联合阿德福韦酯对乙肝患者血清标志物水平的影响①
揭广娴 ② ,黄 华,吴春怡
(廉江市人民医院,广东 廉江 524400)
摘要 目的:分析复方甘草酸苷联合阿德福韦酯对乙肝患者血清标志物水平的影响。 方法:选取 88例乙肝患者,按照随机数字表法分为对照组和观察组,每组各 44 例。对照组采用阿德福韦酯治疗,观察组在对照组的基础上加用复方甘草酸苷治疗,比较两组乙肝病毒血清标志物、肿瘤坏死因子-α(TNF-α)、生长转化因子(TGF-β1)及不良反应。 结果:观察组乙肝 e 抗体(HBeAb)转阳率、脱氧核糖核酸(HBV-DNA)转阴率、乙肝表面抗原(HBsAg)转阴率及乙肝病毒 e 抗原(HBeAg)转阴率均高于对照组(P<0.05);TNF-α、TGF-β1 水平均低于对照组,两组比较差异有统计学意义(P<0.05);两组不良反应总发生率比较,差异无统计学意义(P>0.05)。 结论:复方甘草酸苷联合阿德福韦酯治疗乙肝,能够降低乙肝病毒活跃度及 TNF-α、TGF-β1 水平,且具有较高安全性。
关键词: 乙肝;复方甘草酸苷;阿德福韦酯;血清标志物
中图分类号:R512.62 文献标志码:A 文章编号:1008-2409(2022)03-0001-04
Effect of compound glycyrrhizin combined with adefovir dipivoxil on the serum marker level inpatients with hepatitis B ①
JIE Guangxian ② , HUANG Hua, WU Chunyi.(The People’ s Hospital of Lianjiang, Zhanjiang524400, China)
Abstract Objective: To analyze the effect of compound glycyrrhizin combined with adefovir dipivoxil onserum marker level in patients with hepatitis B. Methods: A total of 88 patients with hepatitis B were randomized into the control group and observation group, each with 44 cases. The control group were given oral adefovir dipivoxil, while the observation group were given compound glycyrrhizin on the basis of the treatment for the control group. The serum marker level of hepatitis B virus, tumor necrosis factor-α(TNF-a), growth transforming factor(TGF-β1)and adverse reactions were compared between the two groups. Results: The conversion rates of hepatitis B e antibody(HBeAb)positive, deoxyribonucleic acid(HBV-DNA)negative, hepatitis B surface antigen(HBsAg)negative and hepatitis B virus e antigen(HBeAg)negative in the observation group were higher than those in the control group; the levels of TNF-α and TGF-β1 were lower than those in the control group, and the difference were statistically significant (P<0.05); there was no statistical significance in the total incidence of adverse reactions between the two groups(P>0.05).Conclusion: For patients with hepatitis B, compound glycyrrhizin combined with adefovir dipivoxil can reduce the activity of hepatitis B virus and the levels of TNF-α and TGF-β1. Besides, it is of high safety in use.
Keywords: hepatitis B; compound glycyrrhizin; adefovir dipivoxil; serum marker
参考文献:
[1] 刘峰,聂仁丽,蔡博,等.异甘草酸镁注射液联合恩替卡韦对慢性乙型肝炎患者肝功能和 sICAM-1、sFas 水平的影响[J].药物评价研究,2021,44(7):1449-1452.
[2] 邱少霞.肝爽颗粒联合多烯磷脂酰胆碱注射液治疗慢性乙型肝炎的效果及对肝功能和肝纤维化水平的影响[J].中国医学创新,2020,17(26):5-9.
[3] 罗颖敏,许飞,胡江玲,等.干扰素对恩替卡韦应答不佳的慢性乙肝且 HBeAg 阳性患者的疗效观察[J].江西医药,2017,52(6):507-508,514.
[4] 张丽娜,蒋明光,黄启功,等.水飞蓟素胶囊联合阿德福韦酯、拉米夫定治疗对失代偿期乙肝肝硬化患者肝功能及血清病毒学指标的影响[J].广西医科大学学报,2019,36(6):952-956.
[5] 袁元,李静.复方甘草酸苷联合替诺福韦酯对慢性乙型肝炎患者的临床疗效[J].中成药,2019,41(10):2544-2546.
[6] 陈丽萍. 苦参素联合复方甘草酸苷阿德福韦酯治疗HBeAg 阳性慢性乙型肝炎患者临床效果[J].中国药物与临床,2019,19(5):783-786.
[7] 中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010 年版)[J].中国预防医学杂志,2011,12(1):1-15.
[8] 廉华,周涛,胡莲,等.苦黄注射液、复方甘草酸苷、阿德福韦酯三联疗法治疗 HBeAg 阳性慢性乙型肝炎的临床疗效及对患者免疫功能的影响[J].现代中西医结合杂志,2017,26(12):1314-1316.
[9] JUN D W,AHN S B,KIM T Y,et al.Efficacy of pegylated interferon monotherapy versus sequential therapy of entecavir and pegylated interferon in hepatitis B e antigen-positive hepatitis B patients:a randomized,multicenter,phase Ⅲb open-label study ( POTENT Study) [J]. Chinese MedicalJournal,2018,131(14):1645-1651.
[10] 袁媛,陈洁,杨雪梅,等.国产恩替卡韦对 HBeAg 阳性代偿期乙肝肝硬化患者 HBV 复制的抑制效果、血清球蛋白及补体 C3、C4 的影响研究[J].川北医学院学报,2020,35(3):432-435,449.
[11] 李颜霞,李颜丽,刘蒲芳,等.阿德福韦酯、拉米夫定联合微生态制剂治疗乙肝肝硬化的效果及对患者血清sICAM-1和血浆 PKM2 水平的影响[J]. 海南医学,2019,30(20):2612-2615.
[12] 季文媛,卫佳琪.自拟疏肝抑纤经验方联合恩替卡韦片对慢性乙型肝炎肝纤维患者化肝功能,血清肝纤维化标志物及血清 TGF-β1、IL-10、MMP-2 水平的影响[J].环球中医药,2019,12(4):591-594.
[13] 王茂军,罗卫国,陈志富.复方甘草酸苷联合阿德福韦酯治疗慢性乙型肝炎患者的疗效及对其血清 TGF-β1、TNF-α 水平的影响[J].临床和实验医学杂志,2018,17(23):2504-2508.
PDF下载：点击下载
版权所有：华夏医学(Acta Medicinae Sinica) 联系电话：0773-2805467 电子邮箱：huaxia@glmc.edu.cn 地址：广西桂林市临桂区致远路1号桂林医学院明德楼316 (541199)